Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Camille Sabella, MD, practices pediatric infectious diseases in the Center for Pediatric Infectious Diseases in the Pediatrics Institute and Children's Hospital at Cleveland Clinic. He is also an Associate Professor of Pediatrics at the Lerner College of Medicine at Case Western Reserve University School of Medicine.
Dr. Sabella is board-certified in pediatrics and pediatric infectious diseases by the American Board of Pediatrics. His clinical interests include pediatric and neonatal infectious diseases, viral infections, infections in transplant recipients and other immunocompromised patients, and immunizations. His research interests include the immune responses of transplant recipients, infections in immunocompromised patients, hospital-acquired infections, and viral infections.
Dr. Sabella has garnered numerous awards throughout his career, including the Chairman’s Award for Commitment to Education in the Division of Pediatrics, and the Excellence in Teaching Award, both from Cleveland Clinic Children's Hospital.
Dr. Sabella has authored numerous original and review publications and book chapters, and has edited the Cleveland Clinic Intensive Review of Pediatrics textbook. He also directs the annual Pediatric Board Review Symposium at the Cleveland Clinic.
congenital infections, infections in pediatric transplant recipients, pediatric infections, pediatric infectious diseases, viral infections, Clinical Trials, epidemiology, infection control, factitious diseases by proxy, infections in cancer patients, infections in immunocompromised hosts, infections in transplantation, infectious in the immuno compromised host
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Sabella's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.